*Screening for malignancy in women with greater than 20% lifetime risk of breast cancer. *Evaluate breast implants for rupture. *Screening the opposite side breast for malignancy in women with known one sided breast malignancy. *Extent of disease and the presence of multifocality and multicentricity in patients with invasive carcinoma and ductal carcinoma in situ (DCIS). *Evaluate response to neoadjuvant chemotherapy.
Breast MRI
Breast biopsy
Breast ultrasound
Breast imaging
Breast self-examination
Vacuum-assisted breast biopsy
Breast duct endoscopy
Xeromammography